Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's RAS(ON) Inhibitors are designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors are used in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Senior Director of Global GI Cancer Advocacy and Society Engagement will play an important role in driving RevMed's strategy and external partnership with GI cancer patient advocacy groups and societies. This includes initiating and growing RevMed's long-term relationships and strategic alliances to meet GI cancer patients needs and reach RevMed's corporate objectives.
This role will report into the Head of Advocacy and Society Engagement and play an integral role in helping to connect RevMed with the community to whom our work is committed.
The successful candidate will be a highly organized, proactive, resourceful, self-motivated leader with a roll-up-the-sleeves mentality and a strong sense of urgency. They should possess a proven track record of setting, driving, and delivering on objectives and projects, and have demonstrated ability to successfully collaborate with others.